USANA INC
10-Q, 1997-10-31
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Previous: ALLEN ETHAN INTERIORS INC, DEF 14A, 1997-10-31
Next: PILLOWTEX CORP, S-8, 1997-10-31



                                 UNITED STATES
                     SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549
 
                                   FORM 10-Q

(Mark One)
[X]  Quarterly Report Pursuant to Section 13 or 15(d) of the Securities
     Exchange Act of 1934
     For the quarterly period ended September 27, 1997.

                                         or

[ ]  Transition Report Pursuant to Section 13 or 15(d) of the Securities
     Exchange Act of 1934
     For the transition period from _______to _______

                        Commission file number 0-21116

                                   USANA, INC.
             (Exact name of registrant as specified in its charter)

Utah                                                           87-0500306
(State or other jurisdiction of                            (I.R.S. Employer
incorporation or organization)                             Identification No.)
      

                                3838 Parkway Blvd.
                           Salt Lake City,  Utah  84120
               (Address of principal executive offices, Zip Code)

                                 (801)954-7100
              (Registrant's telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports 
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 
1934 during the preceding 12 months (or for such shorter period that the 
registrant was required to file such reports), and (2) has been subject to 
such filing requirements for the past 90 days
Yes [X]  No [ ]

The number of shares outstanding of the registrant's common stock as of 
October 28, 1997 was 6,384,619.



<PAGE>                               USANA, INC.

                 Index to Financial Statements and Exhibits
         Filed with the Quarterly Report of the Company on Form 10-Q
           For the Quarter and Nine Months Ended September 27, 1997


                      PART I.  FINANCIAL INFORMATION


Item 1.      Financial Statements:                                   Page No.
             ---------------------                                   --------

             Consolidated Balance Sheets                                 3

             Consolidated Statements of Earnings                         4-5

             Consolidated Statements of Cash Flows                       6

             Notes to Consolidated Financial Statements                  7-9

Item 2.     Management's Discussion and Analysis
            of Financial Condition and Results of Operations             9-13


                      PART II. OTHER INFORMATION

Item 1.     Legal Proceedings                                           13-14

Item 2.     Changes in Securities                                          14

Item 3.     Defaults upon Senior Securities                                14

Item 4.     Submission of Matters to a Vote of Security Holders            14

Item 5.     Other Information                                              14

Item 6.     Exhibits and Reports on Form 8-K                               14

Signatures                                                                 15






                                     2
<PAGE>USANA, INC. & SUBSIDIARY
CONSOLIDATED BALANCE SHEETS
Unaudited
<TABLE>
<CAPTION>
As of                                              September 27, 1997   December 28, 1996
- -----------------                                  ------------------   -----------------
<S>                                                <C>                  <C>
ASSETS:
Current Assets:
     Cash and cash equivalents                     $ 2,809,793          $  1,130,487
     Accounts receivable, net                          166,750                55,149
     Income tax receivable                                   -               405,503
     Inventories (Note A)                            6,122,844             6,399,128
     Prepaid expenses and other current assets       1,338,622               661,359
     Current maturities of notes receivable             29,322                27,212
     Deferred income taxes                             386,356               361,000
                                                   -----------           -----------
          Total current assets                      10,853,687             9,039,838

Property and equipment, at cost (Note B)            12,898,293            11,549,813

Other assets
     Deposits on machinery                             556,990               423,319
     Notes receivable, less current maturities          23,989                46,252
     Other                                              19,618                19,618
                                                   -----------           -----------
          Total Assets                             $24,352,577           $21,078,840
                                                   ===========           ===========

LIABILITIES AND STOCKHOLDERS'  EQUITY:

Current liabilities:
     Accounts payable                              $ 3,170,061           $ 4,709,028
     Line of credit                                          -             1,500,000
     Other current liabilities (Note C)              3,698,977             2,373,533
                                                   -----------           -----------
          Total current liabilities                  6,869,038             8,582,561

Deferred income taxes                                  245,057               129,000

Stockholders' equity:
     Common stock, no par value:
       Authorized -- 50,000,000 shares, issued
       and outstanding 6,384,619 as of
       September 27, 1997 and 6,351,119 as of 
       December 28, 1996                             7,019,805             6,768,844

     Cumulative foreign currency translation
       adjustment                                      (10,773)                9,786
     Retained earnings                              10,229,450             5,588,649
                                                   -----------           -----------
          Total stockholders' equity                17,238,482            12,367,279
                                                   -----------           -----------
               Total liabilities and
                  stockholders' equity             $24,352,577           $21,078,840
                                                   ===========           ===========
</TABLE>

         The accompanying notes are an integral part of these statements.
                                             3

USANA, INC. & SUBSIDIARY
CONSOLIDATED STATEMENTS OF EARNINGS
Unaudited
<TABLE>
<CAPTION>

Quarter Ended                                  September 27, 1997    September 30, 1996
- ----------------------                         ------------------    ------------------
<S>                                            <C>                   <C>   
Net sales                                      $22,872,592           $16,098,095
Cost of sales                                    4,808,903             3,381,640
                                               -----------           -----------
     Gross profit                               18,063,689            12,716,455

Operating Expenses:
     Distributor incentives                     10,437,691             7,392,919
     Selling, general, and administrative        4,273,139             2,840,268
     Research and development                      385,892               189,956
                                               -----------           -----------
          Total operating expenses              15,096,722            10,423,143
                                               -----------           -----------
          Earnings from operations               2,966,967             2,293,312

Other income (expense):
     Interest income                                54,790                33,883
     Interest expense                               (2,510)              (22,046)
     (Loss) gain on sale of property
          and equipment                            (11,684)               65,028
     Other, net                                      2,149                 7,961
                                               -----------           -----------
          Total other income                        42,745                84,826
                                               -----------           -----------
          Earnings before income taxes           3,009,712             2,378,138

Income taxes                                     1,153,886               920,800
                                               -----------           -----------
          NET EARNINGS                         $ 1,855,826           $ 1,457,338
                                               ===========           ===========
Earnings per common and common
     equivalent share (Note D)                 $      0.29           $      0.23
                                               ===========           ===========
Weighted average common shares outstanding       6,368,163             6,338,141
                                               ===========           ===========

</TABLE>


         The accompanying notes are an integral part of these statements.


                                          4

<PAGE>
USANA, INC. & SUBSIDIARY
CONSOLIDATED STATEMENTS OF EARNINGS
Unaudited
<TABLE>
<CAPTION>

Nine Months Ended                              September 27, 1997    September 30, 1996
- ----------------------                         ------------------    ------------------
<S>                                            <C>                   <C>   
Net sales                                      $61,572,891           $40,867,037
Cost of sales                                   12,962,389             8,488,824
                                               -----------           -----------
     Gross profit                               48,610,502            32,378,213 

Operating Expenses:
     Distributor incentives                     28,593,126            18,547,192
     Selling, general, and administrative       11,646,499             6,982,037
     Research and development                      964,961               473,447
                                               -----------           -----------
          Total operating expenses              41,204,586            28,002,676
                                               -----------           -----------
          Earnings from operations               7,405,916             6,375,537

Other income (expense):
     Interest income                                97,978               127,030
     Interest expense                              (10,293)              (22,430)
     Gain on sale of property and equipment          2,953                70,812
     Other, net                                     15,932                15,508
                                               -----------           -----------
          Total other income                       106,570               186,920
                                               -----------           -----------
          Earnings before income taxes           7,512,486             6,562,457

Income taxes                                     2,871,685             2,516,954
                                               -----------           -----------
          NET EARNINGS                         $ 4,640,801           $ 4,045,503
                                               ===========           ===========
Earnings per common and common
     equivalent share                          $      0.73           $      0.64
                                               ===========           ===========
Weighted average common shares outstanding       6,357,262             6,301,504
                                               ===========           ===========

</TABLE>


         The accompanying notes are an integral part of these statements.


                                          5

<PAGE>
USANA, INC. & SUBSIDIARY
CONSOLIDATED STATEMENTS OF CASH FLOWS
Unaudited
<TABLE>
<CAPTION>

Nine Months Ended                                 September 27, 1997   September 30, 1996
- -------------------------------------             ------------------   ------------------
<S>                                               <C>                  <C>
NET CASH FLOWS FROM OPERATING ACTIVITIES
Net earnings                                      $ 4,640,801          $ 4,045,503
Adjustments to reconcile net earnings to
     net cash provided by (used in)
     operating activities:
     Depreciation and amortization                  1,256,383              467,391
     Gain on sale of property and equipment            (2,953)             (70,812)
     Deferred income taxes                             90,701                  101
     Provision for inventory obsolescence             137,826                    -
     Charitable contributions of equipment              2,974                    -
     Changes in operating assets and 
          liabilities:
          Accounts receivable                        (111,601)             (20,774)
          Income tax receivable                       405,503                    -
          Inventories                                 138,458          ( 3,410,172)
          Prepaid expenses and other assets          (810,934)            (446,548)
          Accounts payable                         (1,538,967)           2,238,313
          Other current liabilities                 1,325,444              712,997
                                                  -----------          -----------
              Net cash provided by operating
                  activities                        5,533,635            3,515,999

NET CASH FLOW FROM INVESTING ACTIVITIES:

     Principal receipts on notes receivable            20,153                6,233
     Issuance of notes receivable                           -              (86,087)
     Purchases of property and equipment           (3,718,536)          (6,159,470)
     Proceeds from the sale of property
         and equipment                              1,113,652              111,000
                                                  -----------          -----------
         Net cash used in investing activities     (2,584,731)          (6,128,324)

NET CASH FLOW FROM FINANCING ACTIVITIES:

     Principal payments on long-term 
         obligations                                        -              (14,819)
     Tax benefit of the exercise of stock
         options                                      148,786                    -
     Proceeds from the exercise of stock
         options                                      102,175              186,050
     (Decrease) increase in line of credit         (1,500,000)           1,000,000
                                                  -----------          -----------
          Net cash (used in) provided by
              financing activities                 (1,249,039)           1,171,231

Effect of exchange-rate changes on cash and
      cash equivalents                                (20,559)              (1,077)
                                                  -----------          -----------
Net increase (decrease) in cash and cash
      equivalents                                   1,679,306           (1,442,171)
Cash and cash equivalents at beginning of period    1,130,487            2,976,406
                                                  -----------          -----------
Cash and cash equivalents at end of period        $ 2,809,793          $ 1,534,235
                                                  ===========          ===========

Supplemental disclosures of cash flow 
     information
Cash paid during the nine-month periods ended
September 27, 1997 and September 30, 1996 for
     Interest                                     $    10,293          $    22,430
     Income taxes                                   1,983,831            3,289,453

</TABLE>


         The accompanying notes are an integral part of these statements.


                                                6
<PAGE>

<PAGE>                           PART I.  FINANCIAL INFORMATION

ITEM 1.  FINANCIAL STATEMENTS

                          NOTES TO THE FINANCIAL STATEMENTS
Basis of Presentation

     The unaudited interim consolidated financial information of USANA, Inc. 
and Subsidiary (the "Company" or "USANA") has been prepared in accordance with 
Article 10 of Regulation S-X promulgated by the Securities and Exchange 
Commission.  Certain information and footnote disclosures normally included in 
financial statements prepared in accordance with generally accepted 
accounting  principles have been condensed or omitted pursuant to such rules 
and regulations.  In the opinion of management, the accompanying interim 
consolidated financial information contains all adjustments, consisting of 
normal recurring adjustments, necessary to present fairly the Company's 
financial position and results of operations as of September 27, 1997, and for 
quarters and nine months ended September 27, 1997, and September 30, 1996. 
These financial statements should be read in conjunction with the audited 
consolidated financial statements and notes thereto included in the Company's 
Annual Report on Form 10-KSB for the year ended December 28, 1996.  The 
results of operations for the quarter and nine months ended September 27, 1997 
may not be indicative of the results that may be expected for the fiscal year 
ending December 27, 1997.

NOTE A - INVENTORIES

Inventories consist of the following:          
<TABLE>
<CAPTION>

                                          September 27, 1997    December 28, 1996
                                          ------------------    -----------------
<S>                                       <C>                   <C>
  Raw materials                           $2,488,880            $2,487,907
  Work in process                            868,058               455,315
  Finished goods                           2,903,732             3,455,906
  Provision for inventory obsolescence      (137,826)                    0
                                          ----------             ---------
                                          $6,122,844            $6,399,128
                                          ==========            ==========
</TABLE>

NOTE B - PROPERTY AND EQUIPMENT

Property and equipment consist of the following:          

                                        September 27, 1997    December 28, 1996
                                        ------------------    -----------------
Building                                $ 5,412,527           $ 5,034,304
Land improvements                           289,325               285,278
Leasehold improvements                       50,898                     0
Laboratory and production equipment       1,427,826             2,337,358
Computer equipment                        4,437,395             2,347,347
Furniture and fixtures                    1,249,753               684,481
Automobiles                                 285,039               285,039
                                         ----------            ----------
                                         13,152,763            10,973,807
Less accumulated depreciation
and amortization                          2,027,255             1,196,779
                                         ----------            ----------
                                         11,125,508             9,777,028
Land                                      1,772,785             1,772,785
                                         ----------            ----------
                                        $12,898,293           $11,549,813
                                         ==========            ==========
NOTE C - OTHER CURRENT LIABILITIES

Other current liabilities consist of the following:
<TABLE>
<CAPTION>
                                           September 27, 1997    December 28, 1996
                                           ------------------    -----------------
<S>                                        <C>                   <C>
Employee compensation and related items    $  440,918            $  400,623
Distributor incentives                        874,228               614,559
Income taxes                                  390,787                95,851
Sales taxes                                   689,347               887,487
Deferred revenue                              613,432               177,488
Other                                         690,265               197,525
                                            ---------             ---------
                                           $3,698,977            $2,373,533
                                            =========             =========
</TABLE>
NOTE D - EARNINGS PER SHARE

     In February 1997, the Financial Accounting Standards Board issued 
Statement of Financial Accounting Standard (SFAS) No. 128, "Earnings per 
Share."  SFAS No. 128 is effective for financial statements for periods ending 
after December 15, 1997, and requires companies to report both "basic" and 
"diluted" earnings per share.  "Basic" earnings per share does not include the 
addition of common stock equivalents to the shares outstanding.  "Diluted" 
earnings per share requires the addition of common stock equivalents to the 
shares outstanding.  Average shares outstanding is the denominator used in 
"basic" earnings per share calculations.  Accordingly, "basic" earnings per 
share will be higher than "diluted" earnings per share.  This statement 
replaces Accounting Principles Board ("APB") Opinion No. 15, "Earnings per 
Share."  The following table illustrates the effect on the Company of 
presenting EPS in accordance with SFAS No. 128.

                              For the Quarter Ended September 27, 1997
<TABLE>
<CAPTION>
                                    Earnings       Shares          Per-Share
                                    (Numerator)    (Denominator)   Amount
                                    -----------    -------------   ---------
<S>                                 <C>            <C>             <C>
Basic EPS
Earnings available to common
shareholders                        $ 1,855,826    6,368,163       $0.29 
                                                                   =========
Effect of Dilutive Securities
Stock options                                 -      263,095
                                    -----------    ---------
Diluted EPS
Earnings available to common 
shareholders                        $ 1,855,826    6,631,258       $0.28 
                                    ===========    =========       ========
</TABLE>

     Options to purchase 490,000 shares of common stock at $15.66 a share were 
outstanding during the quarter.  They were not included in the computation of 
EPS because their exercise price was greater than the average market price of 
the common shares.
<TABLE>
<CAPTION>

                                    For the Quarter Ended September 30, 1996

                                    Earnings      Shares          Per-Share
                                    (Numerator)   (Denominator)   Amount
                                    -----------   -------------   ---------
<S>                                 <C>           <C>             <C>
Basic EPS
Earnings available to common
shareholders                        $ 1,457,338   6,338,141       $0.23 
                                                                  =====
Effect of Dilutive Securities
Stock options                                 -     494,243
                                    -----------   ---------
Diluted EPS
Earnings available to common 
shareholders                        $ 1,457,338   6,832,384       $0.21 
                                    ===========   =========       =====
</TABLE>
<TABLE>
<CAPTION>
                               For the Nine Months Ended September 27, 1997

                               Earnings      Shares           Per-Share
                               (Numerator)   (Denominator)    Amount
                               -----------   -------------    ---------
<S>                            <C>           <C>              <C>
Basic EPS
Earnings available to common
shareholders                   $ 4,640,801   6,357,262        $0.73 
                                                              =====
Effect of Dilutive Securities
Stock options                            -     276,424
                               -----------   ---------

Diluted EPS
Earnings available to common 
shareholders                   $ 4,640,801   6,633,686        $0.70 
                               ===========   =========        =====
</TABLE>
<TABLE>
<CAPTION>
                                For the Nine Months Ended September 30, 1996

                                Earnings       Shares         Per-Share
                                (Numerator)    (Denominator)  Amount
                                -----------    -------------  ---------
<S>                             <C>            <C>            <C>
Basic EPS
Earnings available to common
shareholders                    $ 4,045,503    6,301,504      $0.64 
                                                              =====
Effect of Dilutive Securities
Stock options                             -      352,337
                                -----------    ---------
Diluted EPS
Earnings available to common 
shareholders                    $ 4,045,503    6,653,841      $0.61 
                                ===========    =========      =====
</TABLE>

ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND 
RESULTS             OF OPERATIONS

                         FORWARD-LOOKING STATEMENTS

IN ADDITION TO HISTORICAL INFORMATION, THIS QUARTERLY REPORT ON FORM 10Q 
CONTAINS FORWARD-LOOKING STATEMENTS WITHIN THE MEANING OF SECTION 27A OF THE 
SECURITIES ACT OF 1933, AS AMENDED AND SECTION 21E OF THE SECURITIES EXCHANGE 
ACT OF 1934, AS AMENDED.  THEREFORE, THE COMPANY IS INCLUDING THIS STATEMENT 
FOR THE EXPRESS PURPOSE OF AVAILING ITSELF OF THE PROTECTIONS OF SUCH SAFE 
HARBOR WITH RESPECT TO ALL OF SUCH FORWARD-LOOKING STATEMENTS.  THE 
FORWARD-LOOKING STATEMENTS IN THIS REPORT REFLECT THE COMPANY'S CURRENT VIEWS 
WITH RESPECT TO FUTURE EVENTS AND FINANCIAL PERFORMANCE.  THESE 
FORWARD-LOOKING STATEMENTS ARE SUBJECT TO CERTAIN RISKS AND UNCERTAINTIES, 
INCLUDING THOSE DISCUSSED HEREIN, THAT COULD CAUSE ACTUAL RESULTS TO DIFFER 
MATERIALLY FROM HISTORICAL RESULTS OR THOSE ANTICIPATED.  IN THIS REPORT, THE 
WORDS "ANTICIPATES," "BELIEVES," "EXPECTS," "INTENDS," "FUTURE," "PROJECTED" 
AND SIMILAR EXPRESSIONS IDENTIFY FORWARD-LOOKING STATEMENTS.  READERS ARE 
CAUTIONED TO CONSIDER THE SPECIFIC RISK FACTORS DESCRIBED IN THE COMPANY'S 
ANNUAL REPORT ON FORM 10-KSB FOR THE YEAR ENDED DECEMBER 31, 1996 AND NOT TO 
PLACE UNDUE RELIANCE ON THE FORWARD-LOOKING STATEMENTS CONTAINED HEREIN, WHICH 
SPEAK ONLY AS OF THE DATE HEREOF.  THE COMPANY UNDERTAKES NO OBLIGATION TO 
PUBLICLY REVISE THESE FORWARD-LOOKING STATEMENTS TO REFLECT EVENTS OR 
CIRCUMSTANCES THAT MAY ARISE AFTER THE DATE HEREOF.

RESULTS OF OPERATIONS

1997 COMPARED TO 1996

Net sales increased 42.2% and 50.6% to $22.9 million and $61.6 million from 
$16.1 million and $40.9 million for the quarter and nine months ended 
September 27, 1997, respectively, compared to the same periods in 1996.  The 
growth in net sales is primarily attributable to two factors.  First, the 
Company introduced several new products at its Annual International Convention 
(the "Convention") held in July 1997.  Second, the Company's independent 
distributor base continued to grow resulting in a corresponding increase in 
unit sales.  It should also be noted that a price increase phased in during 
the third quarter of 1997 is expected to contribute modestly to sales in the 
fourth quarter.  Net sales in the US increased 27.0% and 32.0% to $16.0 
million and $43.3 million from $12.6 million and $32.8 million for the quarter 
and nine months ended September 27, 1997, respectively, compared to the same 
periods in 1996.  In comparison, net sales in Canada increased 97.1% and 
125.9% to $6.9 million and $18.3 million from $3.5 million and $8.1 million 
for the quarter and nine months ended September 27, 1997, respectively, 
compared to the same periods in 1996.

Cost of sales as a percent of net sales remained constant at 21.0% for the 
third quarters ended 1997 and 1996.  For the nine-month period ended September 
27, 1997, cost of sales increased, as a percent of net sales, to 21.1% as 
compared to 20.8% for the same period in 1996.  The modest increased in the 
cost of sales percentage for the nine months ended September 27, 1997 was 
influenced by several events.  First, there was an increase in the underlying 
cost of materials and direct labor with no accompanying increase in the price 
the Company charges for its products; however, a price increase was phased in 
during the third quarter of 1997.  Price increases effected during the quarter 
should offset the aforementioned increase in raw material and direct labor 
costs during the fourth quarter.  Second, with the introduction of new 
products and preparation for international expansion, the cost of sales 
percentage has suffered due to customary start-up costs on new products.  
Finally, due to the release of new products and modification of existing 
products, USANA increased its provision for potential inventory obsolescence.

Distributor incentives as a percent of net sales decreased to 45.6% and 
increased to 46.4% from 45.9% and 45.4% for the quarter and nine months ended 
September 27, 1997, respectively, for the same periods in 1996.  The increase 
in distributor incentives for the nine months ended September 27, 1997 as 
compared to the same period in 1996 resulted from the continual maturation of 
the Company's distributor base.  The change in the Company's distributor 
incentives in the third quarter of 1997 compared to the third quarter of 1996 
can be attributed to several factors.  First, the continual maturation of the 
Company's distributor base has caused a corresponding increase in the 
distributor incentives percentage.  Second, during the third quarter of 1997, 
USANA introduced a broad repricing strategy across its product line to help 
manage distributor incentives.  The new price structure creates a spread 
between what the distributor pays for the product versus what the distributor 
receives towards sales volume.  Finally, the Company initiated a change in its 
Leadership Bonus Program where leaders bonuses have been increased from 2% to 
3% of the sales volume generated in a given week.  The combined effect of a 
maturing distributor base, the introduction of the new pricing structure and 
the change in the Leadership Bonus Program resulted in decreased distributor 
incentives of 0.3% in the third quarter of 1997 compared to the same period in 
1996.  Management believes the changes made in the distributor compensation 
plan and the price structure provides an opportunity to better manage 
distributor incentives prospectively.

Selling, general and administrative ("SG&A") expenses increased to $4.3 
million and $11.6 million from $2.8 million and $7.0 million for the quarter 
and nine months ended September 27, 1997, respectively, for the same periods 
in 1996.  As a percent of net sales, SG&A expenses increased to 18.8% for the 
quarter and nine months ended September 27, 1997 from 17.4% and 17.1%, 
respectively, for the same periods in 1996.  The increase in SG&A costs can be 
attributed to several factors.  First, the Company acquired, in the second and 
third quarter of 1996, significant management talent to facilitate future 
growth.  Second, there was a need for additional support services and 
facilities to accommodate the growth in sales volume and the increased number 
of distributors.  Third, in the fourth quarter of 1996, the implementation of 
new customer service software caused inefficiencies that carried into the 
first quarter of 1997.  Finally, the Company made significant capital 
acquisitions of $1.7 million and $3.7 million during the third quarter and 
nine months ended September 27, 1997, respectively.  The depreciation on the 
aforementioned acquisitions and acquisitions made in mid- to late-1996 had the 
effect of increasing SG&A costs as a percent of net sales by approximately 
1.0% for the quarter and nine months ended September 27, 1997 over the same 
periods in 1996.

Research and development ("R&D") expenditures increased to $385,892 and 
$964,961 from $189,956 and $473,447 for the quarter and nine months ended 
September 27, 1997, respectively, compared to the same periods in 1996.   As a 
percent of net sales, R&D expenditures increased to 1.7% and 1.6% from 1.2% 
for the quarter and nine months ended September 27, 1997, respectively, 
compared to the same periods in 1996.  The increase in R&D expenditures is 
evidence of the Company's ongoing commitment to remain at the forefront of the 
nutritional industry.  USANA's team of scientists investigates new 
ingredients, develops new products, coordinates clinical trials and keeps 
abreast of the latest research in nutrition and degenerative diseases 
resulting in the continued development of high quality products.

Net earnings increased to $1.9 million and $4.6 million from $1.5 million and 
$4.0 million for the third quarter and nine months ended September 27, 1997, 
respectively, compared to the same periods in 1996.  Net earnings in the 
quarter and nine months ended September 27, 1997 represented record highs for 
the Company.  Results of operations yielded earnings per common and common 
equivalent shares of $0.29 and $0.73 in the third quarter and nine months 
ended September 27, 1997 compared to $0.23 and $0.64, respectively, for the 
same period in 1996.  The increases in net earnings for the quarter and nine 
months ended September 27, 1997 as compared to the same periods in 1996 are 
due primarily to sales growth.

CONSECUTIVE QUARTER COMPARISON

In the third quarter of 1997, net sales increased to $22.9 million from the 
$21.0 million reported in the second quarter of 1997, an increase of 9.0%.  
Distributor incentives, as a percent of net sales, decreased to 45.6% in the 
third quarter of 1997 from the 46.7% reported in the second quarter of 1997.  
Net earnings grew from $1.7 million in the second quarter to $1.9 million in 
the third quarter of 1997, an increase of 11.8%.  The third quarter of 1997 
represents the second consecutive quarter where earnings growth has exceeded 
that of sales growth.  Earnings growth has outpaced sales growth due to 
distributor incentives and SG&A expenditures decreasing as a percentage of net 
sales.

RECENT DEVELOPMENTS

At the Convention, held July 17-19, 1997, in Salt Lake City, Utah, the Company 
formally announced its plans to expand its presence into the countries of 
Australia and New Zealand during fiscal 1998.  The Company also intends to 
make its products available in the Caribbean in fiscal 1998.  Management 
believes the expansion into Australia and New Zealand, which offer 
considerable market potential and a gateway into Asia, continues on schedule, 
with initial sales expected during the first quarter of 1998 and contribution 
to earnings expected in late-1998.

Also introduced at the Convention were several distributor retention 
programs.  These programs should improve the bottom line for both the Company 
and its distributors.  The programs include a co-branded credit card offered 
through MBNA America (bearing USANA's logo) and a telecommunications program 
offered through UniDial Communications.  A distributor stock purchase plan was 
also introduced at the Convention.

The Company has redefined the calculation of its independent distributor 
base.  The definition of a "current distributor" is one who has made a 
purchase in the most recent twelve-month period.  Management of the Company 
believes the enhanced calculation of its distributors provides a more 
meaningful number on which to evaluate the business.  At the end of the third 
quarter, USANA had approximately 82,000 current distributors compared to 
approximately 52,000 as of September 30, 1996.  The following table restates 
the number of distributors to the approximate number of current distributors 
USANA had at the end of each of the last four fiscal years.

                                       As of fiscal year end                
                              --------------------------------------------
                              12/31/93    12/31/94    12/31/95    12/28/96
                              --------    --------    --------    --------
As previously reported        10,000      20,000      50,000      92,000
Current Distributors          10,000      16,000      34,000      59,000

As previously discussed above, the Company introduced a new pricing structure 
and Leadership Bonus Program during the third quarter of 1997, effective 
September 1, 1997.

LIQUIDITY AND CAPITAL RESOURCES

The Company does not extend credit to its distributors, but requires payment 
prior to shipping products.  This process eliminates the need to create 
receivables for its distributors.  Both the growth of the Company and the 
nature of its business assists in yielding considerable cash flows from 
operations.  USANA generated $5.5 million in cash flows from operations during 
the first nine months of 1997 as compared to the $3.5 million generated in 
1996 for the same period.  The increase in cash flows from operations can 
primarily be attributed to an increase in net earnings, a rise in non-cash 
expenditures, and a benefit realized from the income taxes receivable reported 
at the end of 1996.

At September 27, 1997, current assets of the Company were approximately $10.9 
million and current liabilities totaled approximately $6.9 million, resulting 
in net working capital of $4.0 million compared to net working capital of $.5 
million at December 28, 1996, an increase of $3.5 million.  The Company's 
current ratio was 1.58 to 1 at September 27, 1997, as compared to 1.05 to 1 at 
December 28, 1996.  Cash and cash equivalents increased from $1.1 million at 
December 28, 1996 to $2.8 million as of September 27, 1997, an increase of 
$1.7 million.

During the first nine months of 1997, the Company spent approximately $3.7 
million on property and equipment.  The Company expects to spend an additional 
$3.0 million to establish operations in Australia and New Zealand in the 
fourth quarter of 1997 and in the first quarter of 1998.  The $3.0 million is 
targeted for inventory, capital expenditures, and initial operating costs.

During the nine months ended September 27, 1997, inventory decreased by 
approximately $300,000 (4.9%) from the amount reported at December 28, 1996 of 
$6.4 million to $6.1 million at September 27, 1997.  The $6.1 million in 
inventory on September 27, 1997 represents an increase of approximately 
$800,000 (or 15.1%) from the $5.3 million reported on June 28, 1997.  The 
increase in inventory was caused by the need to increase levels to accommodate 
sales growth, preparation for operations in Australia and New Zealand, and the 
introduction of new products in the third quarter of 1997.

On May 30, 1997, the Company re-negotiated its line of credit.  The new terms 
call for an increase in the available line to $5.0 million form the previously 
available $3.5 million.  The line of credit agreement expires in May 1998.  
The interest rate is computed at the bank's prime rate, or at the option of 
the Company, the LIBOR base rate plus 2.25%.  Certain receivables, 
inventories, and equipment collateralize the line of credit.  The line of 
credit agreement also contains restrictive covenants requiring the Company to 
maintain certain financial ratios.  As of September 27, 1997, the Company was 
in compliance with these covenants.  The Company paid off the balance of $1.5 
million that existed at December 28, 1996, and there was no outstanding 
balance as of September 27, 1997.

The Company believes that its current cash balances, the available line of 
credit, and cash provided by operations will be sufficient to cover its needs 
for the next twelve months.  In the event the Company experiences an adverse 
operating environment or unusual capital expenditure requirements, additional 
financing may be required; however, no assurance can be given that additional 
financing, if required, would be available on favorable terms.

CERTAIN FACTORS THAT MAY AFFECT OPERATING RESULTS

When used in this report, the terms "believes," "anticipates," "expects," and 
similar expressions are intended to identify forward-looking statements.  Such 
statements are subject to certain risks and uncertainties that could cause 
actual results to differ materially from those projected.  Readers are 
cautioned not to place undue reliance on these forward-looking statements, 
which speak only as of the date hereof.  The Company undertakes no obligation 
to publicly release the results of any revisions to forward-looking statements 
that may be made to reflect events or circumstances after the date hereof or 
to reflect the occurrence of unanticipated events.  Important factors that may 
cause results to differ from expectation were reported in the Company's Annual 
Report on Form 10-KSB for the fiscal year ended December 28, 1996.  Except as 
noted elsewhere in this report, the factors identified in those previously 
filed reports continue to be significant considerations for the Company.

                          PART II.   OTHER INFORMATION

ITEM 1.     LEGAL PROCEEDINGS

On March 6, 1996, International Nutrition Company ("INC") filed a patent 
infringement action against eighteen defendants, including USANA, alleging 
infringement of U.S. patent number 4,698,360 (the "'360 patent").  The 
complaint, filed in the United States District Court for the District of 
Connecticut, alleges that USANA's Proflavanol [R] product violates the 
patent.  The complaint seeks preliminary and permanent injunctions against 
USANA that would prohibit further sales of the Proflavanol [R] product.  INC 
also seeks monetary damages, including any profits lost by INC as a result of 
the alleged infringement,  damages suffered by INC resulting from the alleged 
infringement, and attorneys' fees and costs incurred by INC.  Having conducted 
a thorough investigation of the patent and the allegations made in the 
complaint, USANA believes that its manufacture and sale of the Proflavanol [R] 
product does not infringe any valid claim of the asserted patent.  USANA 
intends to vigorously defend its right to continue providing its Proflavanol 
[R] product to its customers and distributors.  There can be no assurance, 
however, that USANA will succeed in its defense of this matter.

On April 17, 1996, an unidentified party filed a request with the United 
States Patent and Trademark Office (PTO) to reexamine the validity of the 
patent now being asserted against USANA.  The PTO has since confirmed the 
validity of each of the patent claims in view of the particular prior art 
cited by the unidentified party.

On March 21, 1997, the Federal Judge responsible for the lawsuit ordered that 
the action not proceed until another lawsuit in France is resolved.  That 
lawsuit does not involve USANA, but involves the question of whether INC has 
any ownership rights in the '360 patent.  On March 25, 1997, the French trial 
court ruled in that action that INC does not own the '360 patent.  That 
decision is now on appeal to the French appellate court.  If that ruling is 
upheld, INC may be barred from proceeding with the infringement action against 
USANA.

ITEM 2.  CHANGES IN SECURITIES.
None.

ITEM 3.    DEFAULTS UPON SENIOR SECURITIES
None.

ITEM 4.    SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
None.

ITEM 5.    OTHER INFORMATION
None.

ITEM 6.    EXHIBITS AND REPORTS ON FORM 8-K

     (a)     Exhibits.
   
     Item 601 Exhibit No. and Description

     11      Statement re Computations of Per Share Earnings (included in Note
             D to the Financial Statements)

     27    Financial Data Schedule

     (b)    Reports on Form 8-K.

            No Current Reports on Form 8-K were filed by the Company during 
            the quarter ended September 27, 1997.




<PAGE>
                                   SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the 
registrant has duly caused this report to be signed on its behalf by the 
undersigned thereunto duly authorized.

                                                USANA, INC.


October 31, 1997                                By:  /s/ Gilbert A. Fuller
- ----------------                                --------------------------
Date                                            Gilbert A. Fuller
                                                Vice President of Finance and 
                                                Principal Financial Officer
































<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from the
company's consolidated financial statements, including consolidated balance
sheets, statements of earnings and statements of cash flows (unaudited) for the
quarter and nine months ended September 27, 1997 and is qualified in its
entirety by reference to such financial statements.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-27-1997
<PERIOD-END>                               SEP-27-1997
<CASH>                                       2,809,793
<SECURITIES>                                         0
<RECEIVABLES>                                  166,750
<ALLOWANCES>                                         0
<INVENTORY>                                  6,122,844
<CURRENT-ASSETS>                            10,853,687
<PP&E>                                      14,925,548
<DEPRECIATION>                               2,027,255
<TOTAL-ASSETS>                              24,352,577
<CURRENT-LIABILITIES>                        6,869,038
<BONDS>                                              0
                                0
                                          0
<COMMON>                                     7,019,805
<OTHER-SE>                                  10,218,677
<TOTAL-LIABILITY-AND-EQUITY>                24,352,577
<SALES>                                     61,572,891
<TOTAL-REVENUES>                            61,572,891
<CGS>                                       12,962,389
<TOTAL-COSTS>                               54,166,975
<OTHER-EXPENSES>                               116,863
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              10,293
<INCOME-PRETAX>                              7,512,486
<INCOME-TAX>                                 2,871,685
<INCOME-CONTINUING>                          4,640,801
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 4,640,801
<EPS-PRIMARY>                                     0.73
<EPS-DILUTED>                                     0.70
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission